Not Tagged
Incarda therapeutics
['atrial fibrillation']
final results from phase 2 instant trial of inrhythm for the treatment of newly diagnosed and recurrent paroxysmal atrial fibrillation presented at 2022 american heart association scientific sessions 
News forum for top stories in Cardiac and Vascular to include cardiovascular, structural heart, PV, EVAR, TAVR, Interventional, neurovascular @PrimeCoreSearch